Overview

Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-11-30
Target enrollment:
Participant gender:
Summary
This is a follow-up study to investigate the long-term safety and explore efficacy of SMUP-IA-01, for the treatment of Knee Osteoarthritis. Subjects who participated in and completed the initial stage of the Phase II trial (NCT05182034) will be followed-up until 60 months.
Phase:
PHASE2
Details
Lead Sponsor:
Medipost Co Ltd.